Overview

Depression in Alzheimer's Disease-2

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Sertraline